Impax Asset Management Group’s Biogen BIIB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.21M | Sell |
33,526
-2,320
| -6% | -$291K | 0.02% | 215 |
|
|
2025
Q1 | $4.91M | Sell |
35,846
-884
| -2% | -$121K | 0.03% | 198 |
|
|
2024
Q4 | $5.62M | Sell |
36,730
-2,080
| -5% | -$318K | 0.03% | 212 |
|
|
2024
Q3 | $7.52M | Buy |
38,810
+11,185
| +40% | +$2.17M | 0.03% | 194 |
|
|
2024
Q2 | $6.4M | Buy |
+27,625
| New | +$6.4M | 0.03% | 204 |
|
|
2024
Q1 | – | Sell |
-3,088
| Closed | -$799K | – | 312 |
|
|
2023
Q4 | $799K | Sell |
3,088
-4
| -0.1% | -$1.04K | ﹤0.01% | 302 |
|
|
2023
Q3 | $795K | Sell |
3,092
-496
| -14% | -$127K | ﹤0.01% | 288 |
|
|
2023
Q2 | $1.02M | Sell |
3,588
-63
| -2% | -$17.9K | ﹤0.01% | 280 |
|
|
2023
Q1 | $1.02M | Sell |
3,651
-173
| -5% | -$48.1K | ﹤0.01% | 277 |
|
|
2022
Q4 | $1.06M | Buy |
+3,824
| New | +$1.06M | ﹤0.01% | 262 |
|
|
2020
Q3 | – | Sell |
-29,618
| Closed | -$7.92M | – | 277 |
|
|
2020
Q2 | $7.92M | Buy |
29,618
+7,000
| +31% | +$1.87M | 0.08% | 129 |
|
|
2020
Q1 | $7.16M | Sell |
22,618
-5,900
| -21% | -$1.87M | 0.1% | 123 |
|
|
2019
Q4 | $8.46M | Sell |
28,518
-3,905
| -12% | -$1.16M | 0.09% | 129 |
|
|
2019
Q3 | $7.55M | Buy |
32,423
+306
| +1% | +$71.2K | 0.1% | 136 |
|
|
2019
Q2 | $7.51M | Sell |
32,117
-13,167
| -29% | -$3.08M | 0.1% | 132 |
|
|
2019
Q1 | $10.7M | Sell |
45,284
-606
| -1% | -$143K | 0.15% | 109 |
|
|
2018
Q4 | $13.8M | Buy |
45,890
+30
| +0.1% | +$9.03K | 0.23% | 86 |
|
|
2018
Q3 | $16.2M | Buy |
+45,860
| New | +$16.2M | 0.23% | 95 |
|